Insights

Michael Sorensen

Board Member at Clinical Ink

Michael Sorensen brings more than 15 years of investment experience and is a member of the Investment Committee at NovaQuest Private Equity. He is responsible for transaction origination, investment policy, fundraising, investor relations and the day-to-day management of NovaQuest Private Equity. In addition, he directs the private equity team in acquisitions, divestitures and oversight of portfolio companies. Prior to NovaQuest, Mr. Sorensen was director at BlackRock’s private equity group, responsible for making investment decisions in a wide variety of geographies and industries, including healthcare, technology and consumer and retail, among others. He also held a variety of board seats while at the firm. Prior to BlackRock, Mr. Sorensen worked at Sorenson Capital (no familial relation), a mid-market private equity firm based in Salt Lake City. Similar to his current role, he analyzed private companies in a wide range of industry sub sectors and geographies. Mr. Sorensen also worked as a consultant for L.E.K. Consulting in Los Angeles, where he worked closely with clients’ senior management on projects that included asset optimization, strategic planning and customer segmentation, primarily in the healthcare and media industries. Mr. Sorensen received a master of business administration from the Wharton School at the University of Pennsylvania, a master of public administration from Harvard University, and a bachelor of science in economics from Brigham Young University.

Roles

  • Board Member

    Current role

Social

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.